Neervannan Seshadri sold TARS

March 17, 2026 · Form 4 insider transaction

Neervannan Seshadri sold 3,125 shares of Tarsus Pharmaceuticals, Inc. at $69.42 per share, a transaction worth $216.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
3,125
Price
$69.42
Total value
$216.9K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 17, 2026
Filing dateMarch 19, 2026
Shares owned after93,979
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

View the original Form 4 on SEC EDGAR